Optogenetics offers mutation-independent vision restoration for IRDs, with promising early-phase results in retinitis ...
AAVantgarde and AGC Biologics have entered into an agreement in which AGC Biologics will provide Good Manufacturing Practice manufacturing for AAVantgarde’s dual-vector gene therapies for inherited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback